glp 1 optimized food GLP-1 Promoting Foods Food Companies Are Targeting Users

As of early 2026, several potent single, dual, and triple incretin receptor agonists are in Phase 2/3 trials for MASH including : Survodutide : A dual glucagon (GCGR)/GLP-1 receptor agonist that has shown significant MASH resolution in Phase 2 trials

(NASDAQ:AMGN) collaboration

We recognized there was a need for a natural solution to address cravings and appetite control, and our consumers studies and published research show that the beneficial bacteria strains used by Pendulum are particularly effective in this area

Protein 9 mg 0%

All hormone and substrate profiles except non-esterified fatty acids (NEFA) and cholecystokinin (CCK) were significantly suppressed (GLP-2 completely suppressed) during the GLP-1 infusion, whereas profiles of NEFA and CCK differed in time course during the two treatments (treatmenttime effect), P<0.0001)